ImmunityBio (IBRX) EBIT Margin (QoQ) (2014 - 2026)
ImmunityBio (IBRX) EBIT Margin (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
ImmunityBio |
7.55 Bn |
7.17 Bn |
43.97 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
1,107.00 |
| Dec 31, 2025 |
456.00 |
| Sep 30, 2025 |
9,625.00 |
| Jun 30, 2025 |
12,031.00 |
| Mar 31, 2025 |
52,888.00 |
| Dec 31, 2024 |
39,537.00 |
| Sep 30, 2024 |
817,306.00 |
| Jun 30, 2024 |
22.85 Mn |
| Mar 31, 2024 |
-17.66 Mn |
| Dec 31, 2023 |
3.63 Mn |
| Sep 30, 2023 |
10.99 Mn |
| Jun 30, 2023 |
-17.67 Mn |
| Mar 31, 2023 |
8.53 Mn |
| Dec 31, 2022 |
-3.93 Mn |
| Sep 30, 2022 |
15.05 Mn |
| Jun 30, 2022 |
45.80 Mn |
| Mar 31, 2022 |
-66.52 Mn |
| Dec 31, 2021 |
9.91 Mn |
| Sep 30, 2021 |
-9.41 Mn |
| Jun 30, 2021 |
3.67 Mn |
